Safety and Efficacy of T10430 Eye Drops in Controlling Paediatric Myopia Progression

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(10 sites)

Jordan

Abdali Hospital, Amman

Istiklal Hospital, Amman

Jordan University Hospital, Amman

Irbid Specialty Hospital, Irbid

Pharmaceutical research center at Jordan University of Science and Technology, Irbid

South Africa

IATROS INTERNATIONAL PTY Ltd, Brandwag

Pretoria Eye Institute Research Foundation, Pretoria

Tunisia

Hôpital Universitaire Tahar Sfar Mahdia, Mahdia

Hôpital Farhat-Hached, Sousse

Hôpital Charles Nicolle, Tunis